99 related articles for article (PubMed ID: 6605372)
1. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule.
Pichichero ME; Insel RA
J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):481-6. PubMed ID: 6605372
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
[TBL] [Abstract][Full Text] [Related]
3. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
[TBL] [Abstract][Full Text] [Related]
4. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
Gilsdorf JR; McDonnell WM
Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
[TBL] [Abstract][Full Text] [Related]
5. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period.
Daum RS; Sood SK; Osterholm MT; Pramberg JC; Granoff PD; White KE; Granoff DM
J Pediatr; 1989 May; 114(5):742-7. PubMed ID: 2785591
[TBL] [Abstract][Full Text] [Related]
6. Serum and salivary antibody responses to non-capsular Haemophilus influenzae antigens in children with meningitis and epiglottitis.
Sly PD; McFarlane P; Mermelstein N; Cripps AW; Roberton DM
Aust Paediatr J; 1988 Apr; 24(2):122-7. PubMed ID: 3260771
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children.
Holmes SJ; Murphy TV; Anderson RS; Kaplan SL; Rothstein EP; Gan VN; Granoff DM
J Pediatr; 1991 Mar; 118(3):364-71. PubMed ID: 1999775
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
10. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
11. A mucosal antibody response following systemic Haemophilus influenzae type B infection in children.
Pichichero ME; Hall CB; Insel RA
J Clin Invest; 1981 May; 67(5):1482-9. PubMed ID: 6971877
[TBL] [Abstract][Full Text] [Related]
12. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
Insel RA; Anderson PW
J Immunol; 1982 Mar; 128(3):1267-70. PubMed ID: 7035561
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
Schreiber JR; Barrus V; Cates KL; Siber GR
J Infect Dis; 1986 Jan; 153(1):8-16. PubMed ID: 3484506
[TBL] [Abstract][Full Text] [Related]
17. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR
J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease.
Goldblatt D; Johnson M; Evans J
Arch Dis Child; 1996 Aug; 75(2):159-61. PubMed ID: 8869201
[TBL] [Abstract][Full Text] [Related]
19. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
Rubin LG; Voulalas D; Carmody L
Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866
[TBL] [Abstract][Full Text] [Related]
20. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.
Musher D; Goree A; Murphy T; Chapman A; Zahradnik J; Apicella M; Baughn R
J Infect Dis; 1986 Dec; 154(6):935-43. PubMed ID: 3491165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
